164 related articles for article (PubMed ID: 17958982)
1. Tolerability of anti-tuberculosis treatment and HIV serostatus.
Lanternier F; Dalban C; Perez L; Bricaire F; Costagliola D; Caumes E
Int J Tuberc Lung Dis; 2007 Nov; 11(11):1203-9. PubMed ID: 17958982
[TBL] [Abstract][Full Text] [Related]
2. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
Kuaban C; Bercion R; Koulla-Shiro S
East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
[TBL] [Abstract][Full Text] [Related]
3. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.
Okwera A; Johnson JL; Vjecha MJ; Wolski K; Whalen CC; Hom D; Huebner R; Mugerwa RD; Ellner JJ
Int J Tuberc Lung Dis; 1997 Oct; 1(5):441-5. PubMed ID: 9441099
[TBL] [Abstract][Full Text] [Related]
5. Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi.
Mwaungulu FB; Floyd S; Crampin AC; Kasimba S; Malema S; Kanyongoloka H; Harries AD; Glynn JR; Fine PE
Bull World Health Organ; 2004 May; 82(5):354-63. PubMed ID: 15298226
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status.
Moreno S; Jarrin I; Iribarren JA; Perez-Elías MJ; Viciana P; Parra-Ruiz J; Gomez-Sirvent JL; Lopez-Aldeguer J; Gutierrez F; Blanco JR; Vidal F; Leal M; Rodríguez Arenas MA; Del Amo J;
Int J Tuberc Lung Dis; 2008 Dec; 12(12):1393-400. PubMed ID: 19017448
[TBL] [Abstract][Full Text] [Related]
7. [Tuberculosis in HIV-positive and HIV-negative drug users in Amsterdam].
Keizer ST; Langendam MW; van Deutekom H; Coutinho RA; van Ameijden FJ
Ned Tijdschr Geneeskd; 1998 Jan; 142(4):184-9. PubMed ID: 9557024
[TBL] [Abstract][Full Text] [Related]
8. Adverse reactions of anti-tuberculosis drugs in hospitalized patients: incidence, severity and risk factors.
Javadi MR; Shalviri G; Gholami K; Salamzadeh J; Maghooli G; Mirsaeedi SM
Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1104-10. PubMed ID: 17823987
[TBL] [Abstract][Full Text] [Related]
9. Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis.
Burman W; Weis S; Vernon A; Khan A; Benator D; Jones B; Silva C; King B; LaHart C; Mangura B; Weiner M; El-Sadr W
Int J Tuberc Lung Dis; 2007 Dec; 11(12):1282-9. PubMed ID: 18229435
[TBL] [Abstract][Full Text] [Related]
10. How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners.
Sonnenberg P; Glynn JR; Fielding K; Murray J; Godfrey-Faussett P; Shearer S
J Infect Dis; 2005 Jan; 191(2):150-8. PubMed ID: 15609223
[TBL] [Abstract][Full Text] [Related]
11. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
[TBL] [Abstract][Full Text] [Related]
12. Effect of HIV infection on tolerability and bacteriologic outcomes of tuberculosis treatment.
Bliven-Sizemore EE; Johnson JL; Goldberg S; Burman WJ; Villarino ME; Chaisson RE;
Int J Tuberc Lung Dis; 2012 Apr; 16(4):473-9. PubMed ID: 22325844
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with tuberculosis treatment default among HIV-infected tuberculosis patients in Thailand.
Kittikraisak W; Burapat C; Kaewsa-ard S; Watthanaamornkiet W; Sirinak C; Sattayawuthipong W; Jittimanee S; Pobkeeree V; Varma JK
Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):59-66. PubMed ID: 18937958
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions.
Lehloenya RJ; Todd G; Badri M; Dheda K
Int J Tuberc Lung Dis; 2011 Dec; 15(12):1649-57. PubMed ID: 22118173
[TBL] [Abstract][Full Text] [Related]
15. [HIV seroprevalence in patients with tuberculosis].
Nagai H; Kawabe Y; Nagayama N; Tanaka Y; Nishiyama M; Suzuki M; Masuda K; Baba M; Hori A; Tamura A; Akagawa S; Machida K; Kurashima A; Yotsumoto H; Mori M; Kimura S
Kekkaku; 2001 Nov; 76(11):679-84. PubMed ID: 11766358
[TBL] [Abstract][Full Text] [Related]
16. Current status of treatment completion and fatality among tuberculosis patients in Spain.
Caylà JA; Caminero JA; Rey R; Lara N; Vallés X; Galdós-Tangüis H;
Int J Tuberc Lung Dis; 2004 Apr; 8(4):458-64. PubMed ID: 15141739
[TBL] [Abstract][Full Text] [Related]
17. Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.
Pineda JA; Aguilar-Guisado M; Rivero A; Girón-González JA; Ruiz-Morales J; Merino D; Ríos-Villegas MJ; Macías J; López-Cortés LF; Camacho A; Merchante N; Del Valle J;
Clin Infect Dis; 2009 Oct; 49(8):1274-82. PubMed ID: 19772387
[TBL] [Abstract][Full Text] [Related]
18. Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review.
Korenromp EL; Scano F; Williams BG; Dye C; Nunn P
Clin Infect Dis; 2003 Jul; 37(1):101-12. PubMed ID: 12830415
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of prophylaxis against tuberculosis in patients infected with HIV].
Arbeláez MP; Arbeláez A; Gómez RD; Rojas C; Vélez L; Arias SL; Nagles J; Peláez LM; Betancourt G; Velásquez G
Biomedica; 2007 Dec; 27(4):515-25. PubMed ID: 18320119
[TBL] [Abstract][Full Text] [Related]
20. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
